SPONSOR
Dr. Zaineb Akram
Total Trials
1
Recruiting
1
Phases
Phase 2
Dr. Zaineb Akram is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Multiple Myeloma Refractory, Multiple Myeloma in Relapse.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dr. Zaineb Akram
How many clinical trials has Dr. Zaineb Akram sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Dr. Zaineb Akram, of which 1 are actively recruiting participants. These trials cover conditions including Multiple Myeloma Refractory, Multiple Myeloma in Relapse. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dr. Zaineb Akram research focus on?
Dr. Zaineb Akram clinical trials span Multiple Myeloma Refractory, Multiple Myeloma in Relapse. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dr. Zaineb Akram clinical trial?
To participate in a Dr. Zaineb Akram trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dr. Zaineb Akram trials with current recruitment status updated daily.
Clinical Trials by Dr. Zaineb Akram
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology